Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
American Journal of Hematology|December 1, 1996
Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)Z R Zeigler, C S Rosenfeld, D F Andrews, et al.Journal of Translational Medicine|August 7, 2012
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patientsNeil L Berinstein, Mohan Karkada, Michael A Morse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.Cancer Gene Therapy|June 2, 2007
Proof concept for clinical justification of network mapping for personalized cancer therapeuticsJ Nemunaitis, N Senzer, I Khalil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanomaNeil N Senzer, Howard L Kaufman, Thomas Amatruda, et al.The Journal of Urology|October 24, 2012
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancerJames M Burke, Donald L Lamm, Maxwell V Meng, et al.Cancer Chemotherapy and Pharmacology|October 12, 2014
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumorsDevalingam Mahalingam, John J Nemunaitis, Laeeq Malik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesM Hidalgo, L L Siu, J Nemunaitis, et al.Journal for Immunotherapy of Cancer|January 18, 2019
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trialUlrich Keilholz, Janice M Mehnert, Sebastian Bauer, et al.Archives of Otolaryngology--Head & Neck Surgery|August 4, 2001
Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neckL L Gleich, J L Gluckman, J Nemunaitis, et al.Pageof 17